Author(s):
Nursyamila Shamsuddin, Fazleen Haslinda Mohd Hatta, Mohd Shihabuddin Ahmad Noorden
Email(s):
shiha@uitm.edu.my
DOI:
10.52711/0974-360X.2026.00010 
Address:
Nursyamila Shamsuddin, Fazleen Haslinda Mohd Hatta, Mohd Shihabuddin Ahmad Noorden*
Faculty of Pharmacy, Universiti Teknologi MARA UiTM, Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor, Malaysia.
*Corresponding Author
Published In:
Volume - 19,
Issue - 1,
Year - 2026
ABSTRACT:
Hepatocellular carcinoma (HCC) is one of the prominent types of primary liver cancer affecting millions of people worldwide. Aberrant expression of non-coding RNAs (ncRNAs) is a key player in regulating hepatocellular HCC. Here, we aimed to identify the role of microRNA-3182 (miR-3182) and long non-coding RNA (lncRNA), mir-497-195 cluster host gene (MIR497HG) in HCC. Computational analysis was used to predict and screen miRNA that regulate MIR497HG and its potential downstream target genes, B-cell lymphoma 2 (Bcl-2) and cyclin D2 (CCND2). The effect of miR-3182 on Bcl-2 and CCND2 expression was further assessed in HCC cell line (HepG2) with miR-3182 mimic and miR-3182 inhibitor to increase and decrease miR-3182 expression, respectively. The cell proliferation was evaluated using MTS assay. Relative expression of miR-3182 and target genes was determined by RT-qPCR. Computational analysis predicted that miR-3182 was targeting MIR497HG, Bcl-2 and CCND2. Expression of miR-3182 was significantly downregulated in HepG2 compared with the WRL-68 cell lines (P<0.05). Meanwhile, the expression of MIR497HG was also significantly downregulated in HepG2 compared with the WRL-68 cell lines (P<0.05). Overexpression of miR-3182 reduced the cell proliferation of HepG2 cells at 24 h post-transfection compared to control (P<0.05). Additionally, overexpression and inhibition of miR-3182 significantly downregulated and upregulated the expression of Bcl-2 and CCCND2 levels in HepG2 cells respectively. It can be concluded that miR-3182 regulates the expression of Bcl-2 and CCND2. miR-3182 may be proposed as a potential therapeutic target for HCC. Taken together, this study provides evidence for post-transcriptional regulation of Bcl-2 and CCND2 by miRNA in HCC cells.
Cite this article:
Nursyamila Shamsuddin, Fazleen Haslinda Mohd Hatta, Mohd Shihabuddin Ahmad Noorden. Regulation of non-coding RNA, microRNA-3182 in Hepatocellular carcinoma. Research Journal of Pharmacy and Technology. 2026;19(1):61-8. doi: 10.52711/0974-360X.2026.00010
Cite(Electronic):
Nursyamila Shamsuddin, Fazleen Haslinda Mohd Hatta, Mohd Shihabuddin Ahmad Noorden. Regulation of non-coding RNA, microRNA-3182 in Hepatocellular carcinoma. Research Journal of Pharmacy and Technology. 2026;19(1):61-8. doi: 10.52711/0974-360X.2026.00010 Available on: https://rjptonline.org/AbstractView.aspx?PID=2026-19-1-10
REFERENCES:
1. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J Clin. 2010; 60 (5): 277-300. doi:10.1002/caac.20073.
2. Fujiwara N, Friedman SL, Goossens N, Hoshida Y. Risk factors and prevention of Hepatocellular carcinoma in the era of precision medicine. Journal of Hepatology. 2018; 68, 526-549.
3. Vescovo T, Refolo G, Vitagliano G, Fimia GM, Piacentini M. Molecular mechanisms of hepatitis C virus-induced Hepatocellular carcinoma. Clinical Microbiology and Infection. 2016; 22: 853-861. http://dx.doi.org/10.1016/j.cmi.2016.07.019.
4. Gupta A, Das A, Majumder K, Arora N, Mayo HG, Singh PP, Beg MS, Singh S. Obesity is independently associated with increased risk of Hepatocellular carcinoma cancer-related mortality: A systematic review and meta-analysis. Am J Clin Oncol. 2018; 41(9): 874-881. doi: 10.1097/COC.000000000000388.
5. Li CL, Lin YK, Chen HA, Huang CY, Huang MT, Chang YJ. Smoking as an independent risk factor for Hepatocellular carcinoma due to the α7-Nachr modulating the JAK2/STAT3 signaling axis. J. Clin. Med. 2019; 8: 1391. doi:10.3390/jcm80913191.
6. Li D, Sedano S, Allen R, Gong J, Cho M, Sharma S. Current treatment landscape for advanced Hepatocellular carcinoma: Patient outcomes and the impact on quality of life. Cancers. 2019; 11 (841): 1-18. doi:10.3390/cancers11060841.
7. Dibyajyoti Saha, Tarashankar Maity, Mayukh Jana, Supradip Mandal. Cancer treatment strategy-An overview. Asian J. Pharm. Tech. 2011; 1(2): 28-33.
8. Dongiovanni P, Romeo S, Valenti L. Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors. World J Gastroenterol. 2014; 20(36): 12495-12955. doi: 10.3748/wjg.v20.i36.12945.
9. Swapnil K, Vijay S. Chandrakant M. Targeted drug delivery: A backbone for cancer Therapy. Asian J. Pharma. Res. 2013; 3(1): 40-46. Available on https://asianjpr.com/HTMLPaper.aspx?Journal=Asian+Journal+of+Pharmaceutical+Research%3bPID%3d2013-3-1-8
10. Ganesh G. Dhakad, Sangita P. Shirsat, Kaveri P. Tmabe, Neha R. Jaiswal. Review on Gene Therapy on Cancer. Research Journal of Pharmacology and Pharmacodynamics. 2022; 14(1): 37-2. doi: 10.52711/2321-5836.2022.00006
11. Armila Sen, Komal Kumar, Shaheen Khan, Priyanka Pathak, Arjun Singh. Current Therapy in Cancer: Advances, Challenges, and Future Directions. Asian Journal of Nursing Education and Research. 2024; 14(1): 77-4. doi: 10.52711/2349-2996.2024.00016
12. Ji LY, Wei M, Liu YY, Di ZL, Li SZ. miR-497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR-588/TUSC1 axis. Oncology Reports. 2021; 46(255). doi: 10.3892/or.2021.8206.
13. Zhuang C, Liu Y, Fu S, Yuan C, Luo J, Huang X, Yang W, Xie W, Zhuang C. Silencing of lncRNA MIR497HG via CRISPR/Cas13d induces bladder cancer progression through promoting the crosstalk between Hippo/Yap and TGF-β/Smad signaling. Frontiers in Molecular Biosciences. 2020; 7. doi: 10.3389/fmolb.2020.616768.
14. Tang G, Wu D, Guo M, Li H. LncRNA MIR497HG inhibits colorectal cancer progression by the miR-3918/ACTG2 axis. Journal of Genetics 2020; 101(27). https://doi.org/10.1007/s12041-022-01367-w.
15. Finnegan EF, Pasquinelli AE. MicroRNA biogenesis: Regulating the Regulators. Crit Rev Biochem Mol Biol. 2013; 48(1): 51-68. doi: 10.3109/10409238.2012.738643.
16. Zhu KP, Ma XL, Zhang CL. LncRNA ODRUL contributes to osteosarcoma progression through the miR-3182/MMP axis. The American Society of Gene and Cell Therapy. 2017: 25(10). http://dx.doi.org/10.1016/j/ymthe.2017.06.027.
17. Wang Q, Zhu Y, Zuo G, Chen X, Cheng J, Zhang S. LINC00858 promotes retinoblastoma cell proliferation, migration and invasion by inhibiting miR-3182. Experimental and Therapeutic Medicine. 2020, 19, 999-1005. doi: 10.3892/etm.20198294.
18. Chen X, Gao J, Liang N. DUXAP8 knockdown inhibits the development of the melanoma by regulating the miR-3182/NUPR1 pathway. Oncology Letters. 2021; 22(495). doi: 10.3892/o1.2021.12756.
19. Xue M, Shi D, Xu G, Wang W. The long noncoding RNA linc00858 promotes progress of lung cancer through miR-3182/MMP2 axis. Artificial Cells, Nanomedicine and Biotechnology. 2019; 47(1): 2091-2097. Doi: 10.1080/21691401.2019.161728.
20. Mo X, Yin W, Huang Y, Guo W, Zhou M, Ye H. Expression of miR-3182 and EBV-miR-BART8-3p in nasopharyngeal carcinoma is correlated with distant metastasis. Int J Clin Exp Pathol. 2018; 11(6): 3134-3140.
21. Chandra R. MiRNA: Biogenesis, functions, gene targets, prediction tools and databases-A review. Research J.Pharm. and Tech. 2017; 10(6): 1834-1839. doi:10.5958/0974-360X.2017.00322.5.
22. Tippabathani J, Nellore J, Suresh X. Computational identification of microRNAs binding to the transcription factors related to dopamine neurons. Research J. Pharm. and Tech. 2018; 11(1): 5520-5528. doi: 10.5958/0974-360X.2018.01005.3.
23. Banu S, Ramakrishnaiah T.N. Screening of Garcinia cambogia for in vitro anti-cancerous activity against colon adenocarcinoma (Caco-2) cell line. Res. J. Pharmacognosy and Phytochem. 2018; 10(4): 272-276. doi:10.5958/0975-4385.201800043.2
24. Schmittegen TD, Lee EJ, Jiang J, Sarkar A, Yang L, Elton TS, Chen C. Real-time PCR quantification of precursor and mature microRNA. Methods. 2008; 44(1): 31-38. doi: 10.1016/j.ymeth.2007.09.006.
25. Shamsuddin N, Mohd Hatta FH, Hasan MH, Ahmad Noorden MS. Identification of microRNAs binding site in the 3’untranslated region of long non-coding RNA, MIR497HG: A bioinformatic prediction. Malaysian Journal of Medicine and Health Sciences. 2024; 20(1): 161-167. doi:10.47836/mjmhs.20.1.21
26. Chen Y, Huang F, Deng L, Tang Y, Li D, Wang T, Fan Y, Tao Q, Tang D. Long non-coding RNA TGLC15 advances Hepatocellular carcinoma by stabilizing Sox4. J Clin Lab Anal. 2020; 34(e23009). https://doi.org/10.1002/jcla.23009.
27. Tian Y, Chen ZH, Wu P, Zhang D, Ma Y, Liy XF, Wang X, Ding D, Cao XC, Yu Y. MIR497HG-derived miR-195 and miR-497 mediate tamoxifen resistance via PI3K/AKT signaling in breast cancer. Advanced Science. 2023; 10. doi: 10.1002/advs.202204819.
28. Wei F, Yang L, Jiang D, Pan M, Tang G, Huang M, Zhang J. Long noncoding RNA DUXAP8 contributes to the progression of Hepatocellular carcinoma via regulating miR-422a/PDK2 axis. Cancer Medicine. 2020; 9, 2480-2490. doi: 10.1002/cam4.2861.
29. Furuta M, Kozaki K, Tanimoto K, Tanaka S, Arii S, Shimamura T, Niida A, Miyano S, Inazawa J. The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in Hepatocellular carcinoma. PLoS ONE 2013; 8(3). doi:10.1371/journal.pone.0060155.
30. Merlin NJ, Parthasarathy V, Manavalan R, Devi P, Meera R. Apoptosis significance and molecular mechanisms-A review. Asian J. Research Chem. 2009; 2(4): 369-375.
31. Tutusaus A, Stefanovic M, Boix L, Cucarull B, Zamora A, Blasco L, Garcia de Frutoos P, Reig M, Fernandez-Checa JC, Mari M, Colell A, Bruix J, Morales A. Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in Hepatocellular carcinoma. Oncotarget. 2018; 9(24), 16701-16717.
32. Ghosh S, Biswas A, Nanda S, Das S, Basak S, Mandal S, Biswas A, Sen DJ, Mahanti B, Saha D. Gene Silencing is one of the most efficient and Promising Functional Genomics tools. Research J. Science and Tech. 2020; 12(3):222-232.
33. Li X, Fang J, Wei G, Chen Y, Li D. CircMMP9 accelerates the progression of Hepatocellular carcinoma through the miR-149/CCND2 axis. J Gastrointest Oncol 2022; 13(4), 1875-1888. https://dx.doi.org/10.21037/jgo-22-677.
34. NasimunIslam N1., Jemimah Naine S., Shaik Jameel, S.S. Khora, Venkat Kumar, Mohanasrinivasan V., C. Subathra Devi, Panneerselvam A. Cytotoxic Property of Cocos nucifera shell Extracts on HeLa Cells. Research J. Pharm. and Tech. 7(5): May, 2014; Page 521-525.
35. Pop MA, Almquist BD. Controlled delivery of microRNAs into primary cells using nanostraw technology. Advanced NanoBiomed Research. 2021; 1. doi: 10.1002/anbr.202000061.